Case number 1:22-cv-00221
Otsuka Pharmaceutical Co., Ltd. et al v. Teva Pharmaceuticals USA, Inc. et al > Summary
Court Case Number 1:22-cv-00221
Filing Date Feb 18, 2022
Termination Date Apr 27, 2022
Court Delaware District Court
Status Dismissed - Other
JudgesLeonard P. Stark
Defendant
Plaintiff Attorneys
4Otsuka Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Otsuka Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Steven J. Balick
Ashby & Geddes
H. Lundbeck A/S
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| RE048059 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Jun 23, 2020 |
| 10307419 | Tablet comprising 7-[4-(4-benzo[b]thiopen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof | Jun 4, 2019 |
| 09939637 | Virtual image display device, head-up display system, and vehicle | Apr 10, 2018 |
| 09839637 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Dec 12, 2017 |
| 08618109 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Dec 31, 2013 |
| 08349840 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Jan 8, 2013 |
| 07888362 | Piperazine-substituted benzothiophenes for treatment of mental disorders | Feb 15, 2011 |
